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Figure 1. Pedigree diagram of the CCOR15155 seizure family. Circles represent 
females, squares represent males. Numbers inside shapes identify each mouse. 
Progenitors (females 13, 14, and male 15) were obtained from UNC. The “index 
case” is male 54 who first exhibited spontaneous generalized seizures at 7 months of 
age. The small numbers near the top of each vertical line indicate the litter number.
Table 3. Chr. 16  (2A) and 5 (2B) SNP 
markers in seizure and non-seizure mice.
Inspection of the genome data set revealed 
that most loci from the 8 CC progenitor 
strains are fixed in a homozygous state.  
Sporadic loci across the genome are 
heterozygous; however, there are several 
large unfixed segments including the 
proximal region of chr. 5 (0-45Mb). We also 
detected a ~350 Kb region on chr. 16 that 
appears to be deleted in 3 of 6 seizure mice, 
but not in any of the non-seizure mice. The 
deletion is 42 kb proximal to the promoter of 
the roundabout guidance receptor 1 gene 
(ROBO1).  It is denoted in the table above as 
“N” for a continuous set of markers distal to 
base pair (bp) position 72231262 and 
proximal to bp position 72611972, suggesting 
that the region between these markers is 
deleted. The chr. 5 data show a region of 
heterozygosity in the seizure mice which is 
fixed in all but one non-seizure mouse.
Table 1. Seizure onset in female and male
mice. This gender difference is statistically
significant (p=0.036; exact 2-sided Wilcoxon
rank sum test).
Overall. A cohort of mice was bred to try to identify the pattern of inheritance of the 
spontaneous seizure trait as well as genetically map the putative mutation(s).  
Electroconvulsive shock was used to measure the seizure threshold of each mouse.  
Brains were analyzed with Nissl stain for gross pathology and Timm stain to assess 
nerve terminal sprouting in the hippocampus.  
Mice. This project is based on the Collaborative Cross (CC) strain OR15155. A 
single mouse from this strain (male #54) was originally identified as having 
spontaneous seizures and we were able to breed him to generate the family that is 
shown in Figure 1. In order to begin mapping the chromosome location of the 
gene(s) underlying the seizure phenotype, males #54 and #97 were mated with 
female mice from another inbred strain FVB/NJ.  First filial (F1) generation mice 
were cross-bred to generate F2 mice. Mice were studied for seizure phenotype by 
daily observation
Genotyping. Tail DNA from a subset of mice was used for SNP genotyping on the 
GigaMUGA platform, a 143,000-probe array based on the Illumina Infinium II 
technology. We have genotyped 11 mice from the Figure 1 pedigree. Six genotyped 
mice are known seizure mice: #367, #54, #97, #161, #191 and #267; and five 
genotyped mice have not been observed to exhibit spontaneous seizures #369, #15, 
#52, #107 and #215. 
Western Blot Analysis. We developed an assay to assess the levels of ROBO protein 
in the brain of control mice. Blots were analyzed with NIH ImageJ which is 
developed specifically for densitometric analysis of images. 
Electroshock Testing. Maximal electroshock seizure threshold (MEST) was 
conducted with F1 mice and parental OR15155 mice to test for the hypothesis that 
MEST will be lower in mice more likely to develop spontaneous seizures later on in 
life. Shocks were delivered via ear-clip electrodes.  The current level at which mice 
first exhibit a generalized seizure is taken as the generalized electroshock seizure 
threshold (GEST).  A maximal seizure is defined by bilateral tonic extension of hind 
limbs.  The current level at which mice exhibit tonic hind limb extension is taken as 
the maximal electroshock seizure threshold (MEST). 
Histopathology. Goals are to cut seizure mouse brains using the cryomicrotome to 
stain them using a Nissl stain (cresyl violet) and Timm stain to analyze them using 
high-powered microscopy. 
BEHAVIORAL SEIZURE PHENOTYPE
Table 3A: Chromosome 16 
Table 3B: Chromosome 5
Background: Studies in epilepsy have focused primarily upon younger patient 
populations, with fewer papers published on adult-onset forms of the disease.  We are 
studying a genetic mouse model representative of adult-onset epilepsy.  The goal of the 
larger project is to identify the gene(s) that is mutated in this unique mouse strain.  Three 
hypotheses were tested: i) behaviorally, a proxy for seizure phenotype can be determined 
earlier in the life cycle, ii) biochemically, a microdeletion found before the promoter 
region of the ROBO gene in chromosome 16 is affecting its expression in seizure mice, 
and iii) there will be pathological changes in seizure mice brains.
Methods: A prospective cohort of mice from the CCOR15155 inbred strain from which 
the seizure mutation(s) arose, and first generation mice created by mating CCOR15155 
seizure mice with FVB/NJ inbred strains were studied.  Seizure threshold was measured 
using electroshock testing.  Western blotting studied the ROBO1 protein.  Nissl and 
Timm staining assessed the morphology of major neuroanatomical structures.
Results: Measurement of electroshock seizure threshold in a series of F1 mice between 
6-8 months of age revealed a single cluster of responses with no evidence for a bimodal 
distribution.  Nissl and Timm staining did not reveal gross brain structural abnormalities. 
Western blot analysis was unsuccessful in testing the hypothesis as described.
Conclusions: Our work provides insight into several biological characteristics of this 
new genetic mouse model of adult-onset epilepsy and forms a foundation upon which 
subsequent studies can build to ultimately identify the underlying gene mutation(s). 
Epilepsy is a common heterogeneous neurological disease characterized by spontaneously 
recurrent seizures and a number of associated behavioral co-morbidities.1 Numerous anti-
epilepsy drugs and other alternative therapies are available to treat patients with epilepsy; 
however, up to 30% of patients do not obtain satisfactory clinical benefit emphasizing the 
need for better understanding of pathophysiology.2 Genetic studies using both animal 
models and patient DNA have been fruitful in providing clues to underlying pathogenic 
mechanisms in epilepsy.  Genetic mouse models in particular have been integral in 
helping to shape the understanding of epilepsy as an “ion channelopathy” of the brain and 
complement human studies in which ion channel gene mutations are documented as 
pathogenic for epilepsy.3,4,5 The three classic seizure mutant strains recognized for their 
important insight into human epilepsy pathogenesis are stargazer, tottering and 
lethargic.6,7,8
The age at which seizures first appear in humans with epilepsy is highly variable and 
dependent on many factors, especially epilepsy subtype.  Overall, a large fraction of cases 
begin early in life, and this includes the vast majority of known genetic causes of epilepsy.  
However, it is becoming more clear that risk for developing epilepsy follows a U-shaped 
curve and begins to increase after the age of 55, and that up to half of these cases are 
idiopathic in nature.9,10,11 The genetic factors that underlie the late onset of common, 
idiopathic forms of generalized epilepsy are mostly unknown and represent a critical gap 
in our knowledge with regard to understanding and treating epilepsy in the largest 
growing segment of the population.13 The rare model studied in this project represents a 
viable means to begin to fill this gap.
PEDIGREE STRUCTURE





AGE OF SEIZURE ONSET
Figure 2. Time line of a representative spontaneous behavioral seizure expressed by male 191 
(October 2017).  The seizure begins with the mouse becoming immobile and exhibiting a facial 
grimace (A).  Subtle head bobbing is observed several seconds later (B).  This is followed by 
unilateral forepaw clonus (C) which becomes bilateral and then generalizes, with the mouse losing 
postural control and exhibiting dorsoflexion (D), as well as bilateral hind limb clonus (E and F).  
The mouse retains an abnormal posture in the immediate postical phase (G), and this persists for 
some time (H) before some locomotor activity is observed (I).  It typically takes 5-10 minutes 
following a seizure before mice exhibit normal home cage behavior.
Figure 3. Maximal electroshock seizure threshold (MEST) in F1 (A) and 
parental (B) OR15155 mice.  We tested the hypothesis that the putative 
seizure mutation(s) lowers MEST, and that this effect can be detected prior to 
the onset of spontaneous seizures.  MEST was measured using a ramp-up 
method (daily shock via earclip electrodes and step-wise current increase) when 
mice were 4-6 months of age, at a time when none had been observed to have 
spontaneous seizures.  Both females (N=16) and males (N=11) were studied. A 
statistically significant gender difference was documented (P < 0.01 Student t-
test). Several outliers were detected (A).  Measurement of MEST in several 
older parental OR15155 mice  (12-14 months of age) revealed a lower range of 
values compared to the younger F1 mice (B) for both genders.  The female with 
the lowest MEST and the 2 males with the lowest MEST are known to express 
spontaneous seizures. 
DISTRIBUTION OF SEIZURES IN F2 MICE
Our laboratory has discovered a unique adult-onset mouse model of genetic epilepsy. It is unique because previous 
mouse models of epilepsy begin in the neonatal or juvenile period. We plan to use this model to map and identify the 
causative gene mutation(s).  Results presented in this Capstone project provide a preliminary characterization of the 
seizure phenotype, a basic histological analysis of the mouse brains, and the genetic mode of inheritance as well as 
information on genome-wide analysis of single nucleotide polymorphisms that may help to shed light on structural 
genetic alterations in these seizure mice. Future directions of this work should take into consideration genetic mapping 
and a larger number of histological subjects for analysis. Overall, our work provides initial insight into several 
biological characteristics of this new genetic mouse model of adult-onset epilepsy and forms a foundation upon which 
subsequent studies can build to ultimately identify the underlying gene mutation(s).
SUMMARY AND CONCLUSIONS
Table 2. Distribution of seizures among F1 and F2 
intercross mice. Mice were gently handled and 
systematically observed for 20 minutes each week 
starting at the time of weaning (~1 month).  Expression 
of behavioral seizures was recorded by a trained 
observer.  The age of onset for female F2 mice was 6.5 
+ 2.4 months; for males it was 6.9 + 3.3 months.  Age of 
onset in F2 generation female mice is notably lower 
than in parental OR15155 female mice.  The ratio of 
seizure to non-seizure F2 females (1:4.5) is not 
significantly different  than the ratio for F2 males (1:2) 
(P = 0.1, Fisher’s Exact t-test).
Histopathology
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Seizure mouse (#97, 191, 267) and non-seizure mouse (#52, 191, 215) brains were successfully fixed in paraformaldehyde and cut in 10 micrometer 
slices using the cryomicrotome. The olfactory bulb and the cerebellum were removed before taking slides from every mouse except #267, whose 
cerebellum was left intact. Eighty slides were obtained from each animal. Twenty-five percent of each brain was stained using the Nissl stain (using 
cresyl violet) on every fourth slide. Every eighth slide was stained using Timm Stain. Results of representative Nissl and Timm stains for seizure and 
non-seizure mouse brains can be seen in figures 5-7.
Figure 4. Western blot assay to measure ROBO1 in brain frontal cortex from naïve FVB/NJ 
mice. As seen in Figure 4, Molecular weights are in kD. On left, Western blot 1 shows eight lanes 
with equal amounts of loaded mouse brain tissue. Center, Western blot is shown with the addition of 
both primary ROBO1 antibody and secondary antibody after the usage of blocking agent. A band is 
prominent at ~150kD at the red arrow. On right, Western blot 2 depicts the use of secondary 
antibody without primary antibody. Notice the disappearance of what we presume is ROBO1 at 
~150kD on the left. 
Figure 5 Above. Mouse 52 
(non-seizure mouse) 
hippocampus with Nissl stain on 
left and Timm stain on right. 
Slide #17 was used for the Nissl 
stain and slide #18 was used for 
the Timm stain. 
Figure 6 Below. Mouse #97 
(seizure mouse) hippocampus 
with Nissl stain on left and 
Timm Stain on right. Slide 
#37 was used for the Nissl 
stain and slide #34 was used 
for the Timm Stain. 
Figure 7 Above. Mouse #267 (seizure 
mouse) cerebellum with Nissl stain on 
left and Timm Stain stain on right.
Slide #7 was used for the Nissl and #8 
was used for the Timm Stain.
Western Blot Analysis
